在神经退行性疾病中,用托科特里昂醇调节NF-κB信号通路
Shin Yii Ang1, Saatheeyavaane Bhuvanendran2,3, Vanessa Lin Lin Lee2
1Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, 47500, Petaling Jaya, Selangor, Malaysia.
Discover mental health
|October 24, 2025
概括
托科特里昂醇 (T3),一种维生素E的形式,显示出治疗神经退行性疾病 (ND) 的前景. 进一步研究其对NF-κB通路的影响对于了解其在治疗ND方面的治疗潜力至关重要.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经退行性疾病 (ND) 是一个日益严重的全球健康挑战,特别是随着人口老龄化.
- 现有的ND治疗方法有限,需要探索替代治疗策略.
- 托科特里昂醇 (T3),一种维生素E的形式,表现出抗氧化,抗癌和抗炎性质,表明潜在的治疗益处.
研究的目的:
- 研究托科特里昂醇 (T3) 作为神经退行性疾病 (ND) 的治疗剂的潜力.
- 阐明T3在ND的背景下发挥其有益作用的潜在机制.
- 探索NF-κB信号通路在T3对ND的治疗作用中的作用.
主要方法:
- 对ND,心血管疾病和骨质疏松症的T3补充剂现有临床研究的审查.
- 生物化学途径的分析,特别是NF-κB信号通路,涉及神经炎症和ND.
- 文学综合将T3已知的特性与其在ND中的潜在作用机制联系起来.
主要成果:
- 临床研究表明,补充T3可以缓解ND,心血管疾病和骨质疏松症的症状.
- NF-κB信号通路与神经炎症和ND的进展密切相关.
- T3具有特性,表明它可以调节与ND相关的炎症途径.
结论:
- 托科特里昂醇 (T3) 是治疗神经退行性疾病的潜在治疗候选物.
- 了解T3与NF-κB通路的相互作用是验证其在ND治疗中的有效性的关键.
- 对T3机制的进一步研究可以为新型ND疗法铺平道路.
相关概念视频
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Nitric Oxide Signaling Pathway
6.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.1K
Neurogenesis and Regeneration of Nervous Tissue
1.5K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.5K
Regulated Protein Degradation
3.0K
3.0K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K


